Free Trial

Comerica Bank Buys 6,430 Shares of Exponent, Inc. (NASDAQ:EXPO)

Exponent logo with Business Services background

Comerica Bank lifted its stake in Exponent, Inc. (NASDAQ:EXPO - Free Report) by 2.8% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 239,337 shares of the business services provider's stock after purchasing an additional 6,430 shares during the period. Comerica Bank owned 0.47% of Exponent worth $21,325,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Private Trust Co. NA boosted its holdings in Exponent by 129.8% during the fourth quarter. Private Trust Co. NA now owns 278 shares of the business services provider's stock worth $25,000 after buying an additional 157 shares during the last quarter. Atala Financial Inc acquired a new position in Exponent during the fourth quarter valued at approximately $25,000. Westside Investment Management Inc. acquired a new position in Exponent during the third quarter valued at approximately $26,000. Tortoise Investment Management LLC increased its stake in Exponent by 76.7% in the fourth quarter. Tortoise Investment Management LLC now owns 440 shares of the business services provider's stock valued at $39,000 after purchasing an additional 191 shares in the last quarter. Finally, Trust Co. of Vermont acquired a new stake in Exponent in the fourth quarter worth $45,000. 92.37% of the stock is currently owned by institutional investors.

Exponent Trading Down 1.3 %

Shares of EXPO stock traded down $1.04 on Friday, hitting $76.78. The stock had a trading volume of 585,746 shares, compared to its average volume of 241,659. The firm has a market cap of $3.90 billion, a P/E ratio of 36.22 and a beta of 0.84. Exponent, Inc. has a twelve month low of $73.37 and a twelve month high of $115.75. The company has a fifty day moving average price of $80.59 and a two-hundred day moving average price of $89.67.

Exponent (NASDAQ:EXPO - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The business services provider reported $0.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.48 by $0.04. Exponent had a return on equity of 27.27% and a net margin of 19.52%. The company had revenue of $137.44 million during the quarter, compared to the consensus estimate of $134.63 million. During the same period in the prior year, the company earned $0.59 earnings per share. The company's revenue for the quarter was up .2% compared to the same quarter last year. On average, analysts expect that Exponent, Inc. will post 1.98 earnings per share for the current year.

Exponent Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 20th. Stockholders of record on Friday, June 6th will be given a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 1.56%. The ex-dividend date is Friday, June 6th. Exponent's dividend payout ratio is 56.60%.

Insider Transactions at Exponent

In related news, VP Richard Reiss sold 1,736 shares of Exponent stock in a transaction that occurred on Wednesday, February 26th. The stock was sold at an average price of $85.93, for a total value of $149,174.48. Following the sale, the vice president now owns 1,800 shares of the company's stock, valued at approximately $154,674. This trade represents a 49.10 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 2.10% of the stock is owned by insiders.

About Exponent

(Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

Read More

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

Should You Invest $1,000 in Exponent Right Now?

Before you consider Exponent, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.

While Exponent currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy Early: 3 Tech Trends With Millionaire-Making Potential
SMCI Stumbles on Earnings: Why Some Investors Still Want In
5 Stocks to BUY NOW in May 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines